Schmidli Heinz, Bretz Frank, Racine Amy, Maurer Willi
Novartis Pharma AG, Lichtstrasse 35, 4002 Basel, Switzerland.
Biom J. 2006 Aug;48(4):635-43. doi: 10.1002/bimj.200510231.
Adaptive seamless phase II/III designs combine a phase II and a phase III study into one single confirmatory clinical trial. Several examples of such designs are presented, where the primary endpoint is binary, time-to-event or continuous. The interim adaptations considered include the selection of treatments and the selection of hypotheses related to a pre-specified subgroup of patients. Practical aspects concerning the planning and implementation of adaptive seamless confirmatory studies are also discussed.
适应性无缝II/III期设计将II期和III期研究合并为一项单一的验证性临床试验。文中给出了此类设计的几个例子,其中主要终点为二元变量、事件发生时间或连续性变量。所考虑的期中适应性包括治疗的选择以及与预先指定的患者亚组相关的假设的选择。还讨论了适应性无缝验证性研究规划和实施的实际问题。